Form 8-K - Current report:
SEC Accession No. 0000950170-21-005288
Filing Date
2021-12-20
Accepted
2021-12-20 17:03:04
Documents
15
Period of Report
2021-12-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rkda-20211214.htm   iXBRL 8-K 57406
2 EX-10.1 rkda-ex10_1.htm EX-10.1 132856
3 EX-99.1 rkda-ex99_1.htm EX-99.1 17225
4 GRAPHIC img192114479_0.jpg GRAPHIC 3985
  Complete submission text file 0000950170-21-005288.txt   351538

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rkda-20211214_lab.xml EX-101.LAB 13352
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rkda-20211214.xsd EX-101.SCH 2481
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rkda-20211214_pre.xml EX-101.PRE 9839
9 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20211214_htm.xml XML 4672
Mailing Address 4222 E. THOMAS RD SUITE 320 PHOENIX X1 85018
Business Address 202 COUSTEAU PLACE SUITE 200 DAVIS X1 95618 602-429-0471
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37383 | Film No.: 211505954
SIC: 0100 Agricultural Production-Crops